ENTRY       D10135                      Drug
NAME        Macitentan (JAN/USAN);
            Opsumit (TN)
PRODUCT     OPSUMIT (Actelion Pharmaceuticals US)
FORMULA     C19H20Br2N6O4S
EXACT_MASS  585.9633
MOL_WEIGHT  588.2729
CLASS       Cardiovascular agent
             DG01502  Endothelin receptor antagonist
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2190
            ATC code: C02KX04
            Product: D10135<JP/US>
EFFICACY    Antihypertensive, Endothelin receptor antagonist
  DISEASE   Pulmonary arterial hypertension [DS:H01621]
COMMENT     Pulmonary arterial hypertension, idiopathic pulmonary fibrosis, oncology
TARGET      EDNR [HSA:1909 1910] [KO:K04197 K04198]
  PATHWAY   hsa04080(1909+1910)  Neuroactive ligand-receptor interaction
            hsa04270(1909)  Vascular smooth muscle contraction
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C02 ANTIHYPERTENSIVES
               C02K OTHER ANTIHYPERTENSIVES
                C02KX Antihypertensives for pulmonary arterial hypertension
                 C02KX04 Macitentan
                  D10135  Macitentan (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Pulmonary Antihypertensives
               Endothelin Receptor Antagonists
                Macitentan
                 D10135  Macitentan (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               219  Miscellaneous
                2190  Miscellaneous
                 D10135  Macitentan (JAN/USAN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01502  Endothelin receptor antagonist
               D10135  Macitentan
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D10135  Macitentan
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Endothelin
                EDNR
                 D10135  Macitentan (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10135
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10135
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10135
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10135
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10135
DBLINKS     CAS: 441798-33-0
            PubChem: 135626853
            ChEBI: 76607
            LigandBox: D10135
ATOM        32
            1   S4a S    26.3200  -21.2800
            2   N1b N    27.5100  -21.9800
            3   N1b N    25.1300  -21.9800
            4   O3c O    27.3000  -20.3000
            5   O3c O    25.3400  -20.3000
            6   C1b C    23.9400  -21.2800
            7   C1b C    22.7500  -21.9800
            8   C1a C    21.5600  -21.2800
            9   C8y C    27.5100  -23.3800
            10  N5x N    26.3200  -24.0800
            11  C8x C    26.3200  -25.4800
            12  N5x N    27.5100  -26.1800
            13  C8y C    28.7000  -25.4800
            14  C8y C    28.7000  -24.0800
            15  C8y C    29.8900  -23.3800
            16  C8x C    31.0800  -24.0800
            17  C8x C    32.3400  -23.3800
            18  C8y C    32.3400  -21.9800
            19  C8x C    31.1500  -21.2800
            20  C8x C    29.8900  -21.9800
            21  X   Br   33.5300  -21.2800
            22  O2a O    29.8900  -26.1800
            23  C1b C    31.0800  -25.4800
            24  C1b C    32.2700  -26.1800
            25  O2a O    33.4600  -25.4800
            26  C8y C    34.6500  -26.1800
            27  N5x N    34.6500  -27.5800
            28  C8x C    35.9100  -28.2800
            29  C8y C    37.1000  -27.5800
            30  C8x C    37.1000  -26.1800
            31  N5x N    35.9100  -25.4800
            32  X   Br   38.2900  -28.2800
BOND        34
            1     1   2 1
            2     1   3 1
            3     1   4 2
            4     1   5 2
            5     3   6 1
            6     6   7 1
            7     7   8 1
            8     2   9 1
            9     9  10 2
            10   10  11 1
            11   11  12 2
            12   12  13 1
            13   13  14 2
            14    9  14 1
            15   14  15 1
            16   15  16 2
            17   16  17 1
            18   17  18 2
            19   18  19 1
            20   19  20 2
            21   15  20 1
            22   18  21 1
            23   13  22 1
            24   22  23 1
            25   23  24 1
            26   24  25 1
            27   25  26 1
            28   26  27 2
            29   27  28 1
            30   28  29 2
            31   29  30 1
            32   30  31 2
            33   26  31 1
            34   29  32 1
///
